Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting
Research To Practice | Oncology Videos · Dr. Neil Love
August 8, 202249m 48s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Ezra Cohen, including the following topics:
- Spectrum of targetable mutations in thyroid cancer and impact on treatment selection (0:00)
- Comparative efficacy of TRK inhibitors in patients with thyroid cancer, including those with CNS disease (6:06)
- Current and emerging roles of immunotherapy alone and in combination with tyrosine kinase inhibitors for patients with head and neck cancer (10:17)
- Predicting clinical response to immunotherapy for patients with head and neck cancers (19:47)
- Role of dose reduction in managing toxicities associated with immunotherapy and targeted agents (26:01)
- Current and potential roles for cell-free DNA testing and minimal residual disease assessment in the management of head and neck cancer (32:08)
- Recently reported efficacy data with avasopasem in the treatment of radiation-induced oral mucositis (35:27)
- Factors affecting response to immunotherapy (42:07)